Clayton C. Yates, Ph.D. - Publications

Affiliations: 
2005 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Pathology, Biomedical Engineering, Oncology

89 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Mitra Ghosh T, Mazumder S, Davis J, Yadav J, Akinpelu A, Alnaim A, Kumar H, Waliagha R, Church Bird AE, Rais-Bahrami S, Bird RC, Mistriotis P, Mishra A, Yates CC, Mitra AK, et al. Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers. Cancer Research Communications. 3: 1286-1311. PMID 37476073 DOI: 10.1158/2767-9764.CRC-22-0427  0.511
2022 Mazumder S, Mitra Ghosh T, Mukherjee UK, Chakravarti S, Amiri F, Waliagha RS, Hemmati F, Mistriotis P, Ahmed S, Elhussin I, Salam AB, Dean-Colomb W, Yates C, Arnold RD, Mitra AK. Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer. Cancers. 14. PMID 36497496 DOI: 10.3390/cancers14236009  0.531
2021 Mitra Ghosh T, White J, Davis J, Mazumder S, Kansom T, Skarupa E, Barnett GS, Piazza GA, Bird RC, Mitra AK, Yates C, Cummings BS, Arnold RD. Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer. Frontiers in Pharmacology. 12: 736951. PMID 34938177 DOI: 10.3389/fphar.2021.736951  0.513
2020 Jaynes JM, Sable R, Ronzetti M, Bautista W, Knotts Z, Abisoye-Ogunniyan A, Li D, Calvo R, Dashnyam M, Singh A, Guerin T, White J, Ravichandran S, Kumar P, Talsania K, ... ... Yates CC, et al. Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Science Translational Medicine. 12. PMID 32051227 DOI: 10.1126/Scitranslmed.Aax6337  0.302
2020 Dean-Colomb WM, Ahmed S, Karanam B, Wang H, Davis M, Grizzle WE, Gardner K, Yates C. Effect of Kaiso on immune signaling of breast cancer exosomes. Journal of Clinical Oncology. 38: 3088-3088. DOI: 10.1200/Jco.2020.38.15_Suppl.3088  0.332
2020 Julian DR, Buechel H, Kulkarni M, Ismail N, Brown B, Yates CC. IL‐4 Stimulated Macrophages Induce a Pro‐Inflammatory Secretome in Fibroblasts The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.08740  0.642
2019 Haloul M, Oliveira ERA, Kader M, Wells JZ, Tominello TR, El Andaloussi A, Yates CC, Ismail N. mTORC1-mediated polarization of M1 macrophages and their accumulation in the liver correlate with immunopathology in fatal ehrlichiosis. Scientific Reports. 9: 14050. PMID 31575880 DOI: 10.1038/S41598-019-50320-Y  0.66
2019 Pierre CC, Hercules SM, Yates C, Daniel JM. Dancing from bottoms up - Roles of the POZ-ZF transcription factor Kaiso in Cancer. Biochimica Et Biophysica Acta. Reviews On Cancer. 1871: 64-74. PMID 30419310 DOI: 10.1016/J.Bbcan.2018.10.005  0.35
2019 Martini R, Jenkins BD, Yates C, Newman L, Davis M. Abstract A090: The Duffy Antigen Receptor for Chemokines (DARC) influences levels of tumor-associated leukocytes in the breast tumor microenvironment Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-A090  0.303
2019 Lin H, Wang H, White J, Karanam B, Ghebremedhin A, Addai BA, Grizzle WE, Yates C. Abstract 5219: Kaiso as a novel therapeutic target in castration-resistant prostate cancer (CRPC) Cancer Research. 79: 5219-5219. DOI: 10.1158/1538-7445.Sabcs18-5219  0.356
2019 Sable R, Jaynes J, Ronzetti M, Guzman W, Knotts Z, Val Nd, Morgan J, Yates C, Bolormaa B, Rudloff U. Abstract B49: Precision targeting of M2-like macrophages by the innate defense regulator RP-182 in pancreatic cancer and noncancerous diseases Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-B49  0.34
2019 Adu-Addai B, Salam AB, Amin R, Wang H, Lin H, Ghebremedhin A, White J, Jaynes JM, Yates C. Abstract LB-181: CD133 as a disparity stem cell biomarker in African Americans with late-stage prostate cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-181  0.312
2019 Mori J, Williams R, Lin H, Becks A, White J, Karanam B, Yates C, Wang H. Abstract 5133: Identification of distinct gene expression profiles in African Americans and Caucasian men with prostate cancer Cancer Research. 79: 5133-5133. DOI: 10.1158/1538-7445.Am2019-5133  0.314
2019 Ahmed SU, Jenkins B, Adu-Addai B, Karanam B, Davis MB, Grizzle WE, Wang H, Yates CC. Abstract 1525: Kaiso influences immune signaling of breast cancer exosomes Cancer Research. 79: 1525-1525. DOI: 10.1158/1538-7445.Am2019-1525  0.334
2019 Williams RA, Mori J, Lin H, Becks A, Yates C, Wang H. Abstract 1331: Receptor tyrosine kinases are differentially phosphorylated in metastatic castration resistant prostate cancer Cancer Research. 79: 1331-1331. DOI: 10.1158/1538-7445.Am2019-1331  0.344
2018 Jones KM, Karanam B, Jones-Triche J, Sandey M, Henderson HJ, Samant RS, Temesgen S, Yates C, Bedi D. Phage Ligands for Identification of Mesenchymal-Like Breast Cancer Cells and Cancer-Associated Fibroblasts. Frontiers in Oncology. 8: 625. PMID 30619759 DOI: 10.3389/Fonc.2018.00625  0.302
2018 Mukherjee A, Hollern DP, Williams OG, Rayburn TS, Byrd WA, Yates C, Jones JD. A Review of Regulation of Development and Possible Roles in Cancer Progression and Metastasis. Frontiers in Cell and Developmental Biology. 6: 69. PMID 30018953 DOI: 10.3389/Fcell.2018.00069  0.331
2018 Johnson ZI, Jones JD, Mukherjee A, Ren D, Feghali-Bostwick C, Conley YP, Yates CC. Novel classification for global gene signature model for predicting severity of systemic sclerosis. Plos One. 13: e0199314. PMID 29924864 DOI: 10.1371/Journal.Pone.0199314  0.658
2018 Mahoney CM, Imbarlina C, Yates CC, Marra KG. Current Therapeutic Strategies for Adipose Tissue Defects/Repair Using Engineered Biomaterials and Biomolecule Formulations. Frontiers in Pharmacology. 9: 507. PMID 29867506 DOI: 10.3389/Fphar.2018.00507  0.659
2018 Mota R, Parry TL, Yates C, Qiang Z, Eaton SC, Mwiza JM, Tulasi D, Schisler JC, Patterson C, Zaglia T, Sandri M, Willis MS. Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling In Vivo. The American Journal of Pathology. PMID 29758183 DOI: 10.1016/J.Ajpath.2018.04.007  0.68
2018 Mohammed F, Odedina FT, Ibrahim S, Rafindadi AH, Adamu A, Adamu A, Bello A, Aminu SM, Idoko J, Suleiman AM, Rotimi SO, Kaninjing E, Dagne GA, Yates C, Iliyasu Y, et al. Abstract 2638: Overexpressions of cortisol, annexin V and Lost in expression of PD-L1 and DARC proteins are associated with aggressive prostate cancer phenotypes in Black men: A CaPTC Cohort Study Cancer Research. 78: 2638-2638. DOI: 10.1158/1538-7445.Am2018-2638  0.323
2017 Henderson HJ, Karanam B, Samant R, Vig K, Singh SR, Yates C, Bedi D. Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival. Plos One. 12: e0189662. PMID 29244827 DOI: 10.1371/Journal.Pone.0189662  0.335
2017 Woods-Burnham L, Basu A, Cajigas-Du Ross CK, Love A, Yates C, De Leon M, Roy S, Casiano CA. The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models. The Prostate. PMID 29030865 DOI: 10.1002/Pros.23437  0.307
2017 Yates CC, Rodrigues M, Nuschke A, Johnson ZI, Whaley D, Stolz D, Newsome J, Wells A. Multipotent stromal cells/mesenchymal stem cells and fibroblasts combine to minimize skin hypertrophic scarring. Stem Cell Research & Therapy. 8: 193. PMID 28874184 DOI: 10.1186/S13287-017-0644-9  0.785
2017 Sanchez TW, Zhang G, Li J, Dai L, Kellow R, Mirshahidi S, Wall NR, Yates C, Wilson C, Montgomery S, Zhang J, Casiano C. Abstract B05: Differential autoimmune response to glycolysis and plasminogen antigens from aggressive prostate cancer cells in African American and European American men with prostate cancer Cancer Epidemiology, Biomarkers & Prevention. 26. DOI: 10.1158/1538-7755.Disp16-B05  0.315
2017 Ahmed SU, Triphati S, Grizzle WE, Wang H, Yates CC. Abstract 5414: Kaiso influences the exosome profile required to induce cell proliferation, migration and metabolism in breast cancer Cancer Research. 77: 5414-5414. DOI: 10.1158/1538-7445.Am2017-5414  0.359
2017 Sanchez TW, Zhang G, Li J, Dai L, Mirshahidi S, Wall NR, Yates C, Wilson C, Montgomery S, Zhang J, Casiano CA. Abstract 1130: Targeting the tumor-associated autoantigen alpha-enolase in prostate cancer Cancer Research. 77: 1130-1130. DOI: 10.1158/1538-7445.Am2017-1130  0.332
2016 Satish L, Gallo PH, Johnson S, Yates CC, Kathju S. Local Probiotic Therapy with Lactobacillus plantarum Mitigates Scar Formation in Rabbits after Burn Injury and Infection. Surgical Infections. PMID 27788042 DOI: 10.1089/Sur.2016.090  0.666
2016 Hachim D, LoPresti ST, Yates CC, Brown BN. Shifts in macrophage phenotype at the biomaterial interface via IL-4 eluting coatings are associated with improved implant integration. Biomaterials. 112: 95-107. PMID 27760399 DOI: 10.1016/J.Biomaterials.2016.10.019  0.655
2016 Yates CC, Nuschke A, Rodrigues M, Whaley D, Dechant JJ, Taylor DP, Wells A. Improved transplanted stem cell survival in a polymer gel supplemented with tenascin-C accelerates healing and reduces scarring of murine skin wounds. Cell Transplantation. PMID 27452449 DOI: 10.3727/096368916X692249  0.796
2016 Mukherjee A, Jones J, Karanam B, Davis M, Jaynes J, Reams RR, Dean-Colomb W, Yates C. African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression. Cancer Letters. PMID 27424525 DOI: 10.1016/J.Canlet.2016.06.025  0.308
2016 Nuschke A, Rodrigues M, Rivera J, Yates C, Whaley D, Stolz D, Griffith L, Wells A. Epidermal Growth Factor Tethered to β-Tricalcium Phosphate Bone Scaffolds via a High-Affinity Binding Peptide Enhances Survival of Human Mesenchymal Stem Cells/Multipotent Stromal Cells in an Immune-Competent Parafascial Implantation Assay in Mice. Stem Cells Translational Medicine. PMID 27400798 DOI: 10.5966/Sctm.2015-0326  0.777
2016 Quintana MT, Parry TL, He J, Yates CC, Sidorova TN, Murray KT, Bain JR, Newgard CB, Muehlbauer MJ, Eaton SC, Hishiya A, Takayama S, Willis MS. Cardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates p38 Signaling. The American Journal of Pathology. PMID 27321750 DOI: 10.1016/J.Ajpath.2016.03.017  0.668
2016 Bodnar RJ, Satish L, Yates CC, Wells A. Pericytes: A newly recognized player in wound healing. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. PMID 26969517 DOI: 10.1111/Wrr.12415  0.742
2016 Lopez H, Martin GR, Jaynes JM, Yates C. Abstract PR03: Synthetic peptides suppress M2 macrophages and synergize with chemotherapy in prostate and breast cancer models Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-Pr03  0.33
2016 Dean-Colomb W, Tan M, Tang W, Ambs S, Yates C. Abstract P5-08-38: Low lactate dehydrogenase B expression correlates with decreased distant-metastasis free- and recurrence-free survival post-chemotherapy in basal-like breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P5-08-38  0.305
2016 Tripathi S, Karanam B, Ma B, Wells A, Yates C. Abstract 1680: Targeting subcellular localization of Kaiso to limit dissemination through MAPK signaling Cancer Research. 76: 1680-1680. DOI: 10.1158/1538-7445.Am2016-1680  0.529
2016 Gales D, Yates CC, Samuel T. Abstract 1286: Cytokine response of stromal cells to prostate cancer chemotherapeutics Cancer Research. 76: 1286-1286. DOI: 10.1158/1538-7445.Am2016-1286  0.359
2015 Wells A, Nuschke A, Yates CC. Skin tissue repair: Matrix microenvironmental influences. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 26278492 DOI: 10.1016/J.Matbio.2015.08.001  0.743
2015 He J, Quintana MT, Sullivan J, L Parry T, J Grevengoed T, Schisler JC, Hill JA, Yates CC, Mapanga RF, Essop MF, Stansfield WE, Bain JR, Newgard CB, Muehlbauer MJ, Han Y, et al. MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet. Cardiovascular Diabetology. 14: 97. PMID 26242235 DOI: 10.1186/S12933-015-0252-X  0.674
2015 Quintana MT, He J, Sullivan J, Grevengoed T, Schisler J, Han Y, Hill JA, Yates CC, Stansfield WE, Mapanga RF, Essop MF, Muehlbauer MJ, Newgard CB, Bain JR, Willis MS. Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet. Bmc Endocrine Disorders. 15: 36. PMID 26215257 DOI: 10.1186/S12902-015-0028-Z  0.682
2015 Pierre CC, Longo J, Mavor M, Milosavljevic SB, Chaudhary R, Gilbreath E, Yates C, Daniel JM. Kaiso overexpression promotes intestinal inflammation and potentiates intestinal tumorigenesis in Apc(Min/+) mice. Biochimica Et Biophysica Acta. 1852: 1846-55. PMID 26073433 DOI: 10.1016/J.Bbadis.2015.06.011  0.323
2015 Arora R, Schmitt D, Karanam B, Tan M, Yates C, Dean-Colomb W. Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers. Oncotarget. 6: 662-78. PMID 25575825 DOI: 10.18632/Oncotarget.2689  0.323
2015 He J, Quintana MT, Sullivan J, Parry T, Grevengoed T, Schisler JC, Hill JA, Yates CC, Mapanga RF, Essop MF, Stansfield WE, Bain JR, Newgard CB, Muehlbauer MJ, Han Y, et al. MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet Cardiovascular Diabetology. 14. DOI: 10.1186/s12933-015-0252-x  0.646
2015 Quintana MT, He J, Sullivan J, Grevengoed T, Schisler J, Han Y, Hill JA, Yates CC, Stansfield WE, Mapanga RF, Essop MF, Muehlbauer MJ, Newgard CB, Bain JR, Willis MS. Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet Bmc Endocrine Disorders. DOI: 10.1186/s12902-015-0028-z  0.639
2015 Gales DN, Fadlalla K, Manne U, Yates C, Samuel T. Abstract B11: Stromal response to prostate cancer therapeutics Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Pms14-B11  0.356
2015 Ahmed SU, Abdalla MO, Yates C, Jaynes J, Turner T. Abstract 3675: Double receptor targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer Cancer Research. 75: 3675-3675. DOI: 10.1158/1538-7445.Am2015-3675  0.304
2014 Xu L, Yates CC, Lockyer P, Xie L, Bevilacqua A, He J, Lander C, Patterson C, Willis M. MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition. Journal of Molecular and Cellular Cardiology. 77: 86-101. PMID 25257914 DOI: 10.1016/J.Yjmcc.2014.09.011  0.67
2014 Smith BN, Burton LJ, Henderson V, Randle DD, Morton DJ, Smith BA, Taliaferro-Smith L, Nagappan P, Yates C, Zayzafoon M, Chung LW, Odero-Marah VA. Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2. Plos One. 9: e104987. PMID 25122124 DOI: 10.1371/Journal.Pone.0104987  0.365
2014 Jones J, Wang H, Karanam B, Theodore S, Dean-Colomb W, Welch DR, Grizzle W, Yates C. Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clinical & Experimental Metastasis. 31: 497-510. PMID 24570268 DOI: 10.1007/S10585-014-9644-7  0.326
2014 Jones J, Wang H, Karanam B, Theodore S, Dean-Colomb WM, Welch DR, Grizzle WE, Yates C. Nuclear localization of Kaiso as a prognostic biomarker and promotion of EMT in infiltrating ductal breast carcinomas. Journal of Clinical Oncology. 32: e22061-e22061. DOI: 10.1200/Jco.2014.32.15_Suppl.E22061  0.318
2014 Theodore SC, Wang H, Rhim J, Turner T, Davis M, Grizzle W, Yates CC. Abstract PL01-02: Functional biomarkers that promote African American prostate cancer through epigenetic regulation Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-Pl01-02  0.305
2014 Reams RR, Jones JD, Osborne D, Wang H, Yates CC. Abstract C70: ABCD3 expression in prostate and breast tumors Cancer Epidemiology, Biomarkers & Prevention. 23. DOI: 10.1158/1538-7755.Disp13-C70  0.329
2014 Smith BN, Nagappan P, Taliaferro-Smith L, Mezencev R, Yates C, Hinton C, Odero-Marah V. Abstract 1131: Snail- and ERK2-dependent signaling enhances breast cancer cell resistance to hydroxytamoxifen Cancer Research. 74: 1131-1131. DOI: 10.1158/1538-7445.Am2014-1131  0.341
2013 Zhou J, Feigenbaum L, Yee C, Song H, Yates C. Mouse prostate epithelial luminal cells lineage originate in the basal layer where the primitive stem/early progenitor cells reside: implications for identifying prostate cancer stem cells. Biomed Research International. 2013: 913179. PMID 23819124 DOI: 10.1155/2013/913179  0.329
2013 Rodrigues M, Yates CC, Nuschke A, Griffith L, Wells A. The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. Tissue Engineering. Part A. 19: 1972-83. PMID 23541003 DOI: 10.1089/Ten.Tea.2012.0568  0.779
2013 Wang H, Black S, Liu W, Zhao F, Turner T, Yates C. Abstract 3062: Transcriptional repressor Kaiso promotes cancer progression by targeting miR-31 in prostate cancer. Cancer Research. 73: 3062-3062. DOI: 10.1158/1538-7445.Am2013-3062  0.323
2013 Smith BN, Nagappan P, Chetram M, Taliaferro-Smith L, Yates C, Hinton C, Odero-Marah V. Abstract 1485: Snail activation of MAPK pathway may contributes to tumor insensitivity to tamoxifen chemotherapy in breast cancer cells. Cancer Research. 73: 1485-1485. DOI: 10.1158/1538-7445.Am2013-1485  0.379
2013 Arora R, Tan M, Yates C, Dean-Colomb W. Abstract P1-07-07: Targeting reversal of epithelial-mesenchymal transition through FOXM1 inhibition in breast cancer cells Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P1-07-07  0.334
2012 Cerwinka WH, Sharp SM, Boyan BD, Zhau HE, Chung LW, Yates C. Differentiation of human mesenchymal stem cell spheroids under microgravity conditions. Cell Regeneration (London, England). 1: 2. PMID 25408865 DOI: 10.1186/2045-9769-1-2  0.312
2012 Yates CC, Hebda P, Wells A. Skin wound healing and scarring: fetal wounds and regenerative restitution. Birth Defects Research. Part C, Embryo Today : Reviews. 96: 325-33. PMID 24203921 DOI: 10.1002/Bdrc.21024  0.738
2012 Jones J, Wang H, Zhou J, Hardy S, Turner T, Austin D, He Q, Wells A, Grizzle WE, Yates C. Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells. The American Journal of Pathology. 181: 1836-46. PMID 22974583 DOI: 10.1016/J.Ajpath.2012.08.008  0.521
2012 Karna P, Rida PC, Turaga RC, Gao J, Gupta M, Fritz A, Werner E, Yates C, Zhou J, Aneja R. A novel microtubule-modulating agent EM011 inhibits angiogenesis by repressing the HIF-1α axis and disrupting cell polarity and migration. Carcinogenesis. 33: 1769-81. PMID 22678119 DOI: 10.1093/Carcin/Bgs200  0.301
2012 Yates CC, Whaley D, Wells A. Transplanted fibroblasts prevents dysfunctional repair in a murine CXCR3-deficient scarring model. Cell Transplantation. 21: 919-31. PMID 22236446 DOI: 10.3727/096368911X623817  0.746
2012 Wang H, Jones J, Turner T, He QP, Hardy S, Grizzle WE, Welch DR, Yates C. Clinical and biological significance of KISS1 expression in prostate cancer. The American Journal of Pathology. 180: 1170-8. PMID 22226740 DOI: 10.1016/J.Ajpath.2011.11.020  0.354
2012 Smith BN, Nagappan P, Chetram M, Taliaferro-Smith L, Saintil T, Yates C, Hinton C, Odero-Marah V. Abstract 5747: Elucidating the mechanisms by which Snail transcription factor promotes resistance to chemotherapy in breast carcinomas Cancer Research. 72: 5747-5747. DOI: 10.1158/1538-7445.Am2012-5747  0.361
2012 Theodore SC, Davis M, Jhong R, Turner T, Yates C. Abstract B38: Profiling miR-152 expression in African American prostate cancer cell lines. Cancer Epidemiology, Biomarkers & Prevention. 21. DOI: 10.1158/1055-9965.Disp12-B38  0.312
2011 Karna P, Gundala SR, Gupta MV, Shamsi SA, Pace RD, Yates C, Narayan S, Aneja R. Polyphenol-rich sweet potato greens extract inhibits proliferation and induces apoptosis in prostate cancer cells in vitro and in vivo. Carcinogenesis. 32: 1872-80. PMID 21948980 DOI: 10.1093/Carcin/Bgr215  0.346
2011 Zhou J, Wang H, Cannon V, Wolcott KM, Song H, Yates C. Side population rather than CD133+ cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells Molecular Cancer. 10: 112-112. PMID 21917149 DOI: 10.1186/1476-4598-10-112  0.32
2011 Yates CC, Bodnar R, Wells A. Matrix control of scarring. Cellular and Molecular Life Sciences : Cmls. 68: 1871-81. PMID 21390544 DOI: 10.1007/S00018-011-0663-0  0.735
2011 Abdalla MO, Karna P, Sajja HK, Mao H, Yates C, Turner T, Aneja R. Enhanced noscapine delivery using uPAR-targeted optical-MR imaging trackable nanoparticles for prostate cancer therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 149: 314-22. PMID 21047537 DOI: 10.1016/J.Jconrel.2010.10.030  0.306
2011 Yates C, Sharp S, Jones J, Topps D, Coleman M, Aneja R, Jaynes J, Turner T. LHRH-conjugated lytic peptides directly target prostate cancer cells. Biochemical Pharmacology. 81: 104-10. PMID 20869347 DOI: 10.1016/J.Bcp.2010.09.015  0.326
2011 Josson S, Anderson CS, Sung SY, Johnstone PA, Kubo H, Hsieh CL, Arnold R, Gururajan M, Yates C, Chung LW. Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. The Prostate. 71: 232-40. PMID 20672324 DOI: 10.1002/Pros.21237  0.318
2010 Theodore S, Sharp S, Zhou J, Turner T, Li H, Miki J, Ji Y, Patel V, Yates C, Rhim JS. Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient. International Journal of Oncology. 37: 1477-82. PMID 21042716 DOI: 10.3892/Ijo_00000800  0.312
2010 Josson S, Sharp S, Sung SY, Johnstone PA, Aneja R, Wang R, Gururajan M, Turner T, Chung LW, Yates C. Tumor-Stromal Interactions Influence Radiation Sensitivity in Epithelial- versus Mesenchymal-Like Prostate Cancer Cells. Journal of Oncology. 2010. PMID 20798867 DOI: 10.1155/2010/232831  0.342
2010 Aneja R, Miyagi T, Karna P, Ezell T, Shukla D, Vij Gupta M, Yates C, Chinni SR, Zhau H, Chung LW, Joshi HC. A novel microtubule-modulating agent induces mitochondrially driven caspase-dependent apoptosis via mitotic checkpoint activation in human prostate cancer cells. European Journal of Cancer (Oxford, England : 1990). 46: 1668-78. PMID 20303260 DOI: 10.1016/J.Ejca.2010.02.017  0.334
2010 Yates CC, Krishna P, Whaley D, Bodnar R, Turner T, Wells A. Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring. The American Journal of Pathology. 176: 1743-55. PMID 20203286 DOI: 10.2353/Ajpath.2010.090564  0.754
2010 Sun X, He H, Xie Z, Qian W, Yates C, Marshall FF, Zhau HE, Chung LWk, Wang R. Abstract 561: Establishment and characterization of matched pairs of human prostate stromal cells to study cancer-stromal interaction Cancer Research. 70: 561-561. DOI: 10.1158/1538-7445.Am10-561  0.332
2009 Karna P, Sharp SM, Yates C, Prakash S, Aneja R. EM011 activates a survivin-dependent apoptotic program in human non-small cell lung cancer cells Molecular Cancer. 8: 93-93. PMID 19878573 DOI: 10.1186/1476-4598-8-93  0.324
2009 Bodnar RJ, Yates CC, Rodgers ME, Du X, Wells A. IP-10 induces dissociation of newly formed blood vessels. Journal of Cell Science. 122: 2064-77. PMID 19470579 DOI: 10.1242/Jcs.048793  0.747
2009 Yates CC, Whaley D, Hooda S, Hebda PA, Bodnar RJ, Wells A. Delayed reepithelialization and basement membrane regeneration after wounding in mice lacking CXCR3. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 17: 34-41. PMID 19152649 DOI: 10.1111/J.1524-475X.2008.00439.X  0.743
2008 Yates CC, Whaley D, Y-Chen A, Kulesekaran P, Hebda PA, Wells A. ELR-negative CXC chemokine CXCL11 (IP-9/I-TAC) facilitates dermal and epidermal maturation during wound repair. The American Journal of Pathology. 173: 643-52. PMID 18669615 DOI: 10.2353/Ajpath.2008.070990  0.755
2008 Wells A, Yates C, Shepard CR. E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clinical & Experimental Metastasis. 25: 621-8. PMID 18600305 DOI: 10.1007/S10585-008-9167-1  0.503
2007 Yates CC, Whaley D, Kulasekeran P, Hancock WW, Lu B, Bodnar R, Newsome J, Hebda PA, Wells A. Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor. The American Journal of Pathology. 171: 484-95. PMID 17600132 DOI: 10.2353/Ajpath.2007.061092  0.761
2007 Yates CC, Whaley D, Babu R, Zhang J, Krishna P, Beckman E, Pasculle AW, Wells A. The effect of multifunctional polymer-based gels on wound healing in full thickness bacteria-contaminated mouse skin wound models. Biomaterials. 28: 3977-86. PMID 17561250 DOI: 10.1016/J.Biomaterials.2007.05.008  0.73
2007 Yates C, Shepard CR, Papworth G, Dash A, Beer Stolz D, Tannenbaum S, Griffith L, Wells A. Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Advances in Cancer Research. 97: 225-46. PMID 17419948 DOI: 10.1016/S0065-230X(06)97010-9  0.485
2007 Yates CC, Shepard CR, Stolz DB, Wells A. Co-culturing human prostate carcinoma cells with hepatocytes leads to increased expression of E-cadherin. British Journal of Cancer. 96: 1246-52. PMID 17406365 DOI: 10.1038/Sj.Bjc.6603700  0.505
2006 Bodnar RJ, Yates CC, Wells A. IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain. Circulation Research. 98: 617-25. PMID 16484616 DOI: 10.1161/01.Res.0000209968.66606.10  0.726
2005 Yates C, Wells A, Turner T. Luteinising hormone-releasing hormone analogue reverses the cell adhesion profile of EGFR overexpressing DU-145 human prostate carcinoma subline. British Journal of Cancer. 92: 366-75. PMID 15655536 DOI: 10.1038/Sj.Bjc.6602350  0.52
Show low-probability matches.